ChromaVision Sells $18.6 Million in Stock
- Share via
ChromaVision Medical Systems Inc. in San Juan Capistrano said Monday it sold about 1.8 million shares of stock to institutional and other accredited investors.
The company, which makes an imaging system designed to detect and treat cellular diseases, said it will use the proceeds, about $18.6 million, to provide working capital to market its automated cellular imaging system. Prudential Securities Inc.’s Prudential Vector Healthcare Group unit served as the company’s placement agent in the financing.
ChromaVision’s stock rose 11.5%, or $1.56, to $15.13 a share, in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
